Try our Advanced Search for more refined results

Dexcom Fights Abbott's Bid To Invalidate Its Diabetes Tech IP

By Bonnie Eslinger (September 14, 2021, 3:51 PM BST) -- Dexcom Inc. has fought back against rival Abbott Laboratories Ltd.'s bid in the High Court to revoke four of its patents for glucose monitoring systems that track blood sugar levels in diabetics, denying their inventions were obvious in light of earlier medical advances....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!